Literature DB >> 16771577

Nucleoprotein assemblies for cellular biomarker detection.

Elizabeth M Singer1, Steven S Smith.   

Abstract

In this report, we have used DNA Y-junctions as fluorescent scaffolds for EcoRII methyltransferase-thioredoxin (M.EcoRII-Trx) fusion proteins. Covalent links between the DNA scaffold and the methyltransferase were formed at preselected sites on the scaffold containing 5FdC. The resulting thioredoxin-targeted nanodevice was found to bind selectively to certain cell lines but not to others. The fusion protein was constructed so as to permit proteolytic cleavage of the thioredoxin peptide from the nanodevice. Proteolysis with thrombin or enterokinase effectively removed the thioredoxin peptide from the nanodevice and extinguished cell line specific binding measured by fluorescence. A number of potential applications for devices of this type can be envisioned. In particular, the ability of the fused protein to selectively target the nanodevice to certain tumor cell lines and not others suggests that this approach may serve as an adjunct to immunohistochemical methods in tumor classification as well as probe cell surface receptor architecture and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771577     DOI: 10.1021/nl060549h

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  4 in total

1.  Nanotechnology of emerging targeting systems.

Authors:  S S Smith
Journal:  Minerva Biotecnol       Date:  2008-09       Impact factor: 3.028

2.  Biomarker identification with ligand-targeted nucleoprotein assemblies.

Authors:  Elizabeth M Singer; Laura E Crocitto; Yuri Choi; Sofia Loera; Lawrence M Weiss; S Ashraf Imam; Timothy G Wilson; Steven S Smith
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

3.  A directed evolution design of a GCG-specific DNA hemimethylase.

Authors:  Ruta Gerasimaite; Giedrius Vilkaitis; Saulius Klimasauskas
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

4.  Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Authors:  Elizabeth Singer; Jennifer Linehan; Gail Babilonia; S Ashraf Imam; David Smith; Sofia Loera; Timothy Wilson; Steven Smith
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.